146 related articles for article (PubMed ID: 3022528)
1. Search for HTLV-I and LAV/HTLV-III antibodies in serum and CSF of multiple sclerosis patients.
De Rossi A; Gallo P; Tavolato B; Callegaro L; Chieco-Bianchi L
Acta Neurol Scand; 1986 Aug; 74(2):161-4. PubMed ID: 3022528
[TBL] [Abstract][Full Text] [Related]
2. Absence of antibodies to HTLV-I and HIV in serum and cerebrospinal fluid of Italian patients with multiple sclerosis.
Merelli E; Sola P; Montagnani G; Baldini E
J Neurol Sci; 1988 Apr; 84(2-3):337-9. PubMed ID: 2837543
[TBL] [Abstract][Full Text] [Related]
3. HTLV antibodies in Italian patients with multiple sclerosis.
Varmier O; Melioli G; Lillo F; Schito G; Repetto C; Ravegnani M; Battaglia M
Ital J Neurol Sci; 1987 Jun; Suppl 6():51-2. PubMed ID: 2820895
[TBL] [Abstract][Full Text] [Related]
4. Multiple sclerosis and human T-cell lymphotropic retroviruses: negative serological results in 135 German patients.
Schneider J; Kitze B; Hunsmann G; Wendler I; Kappos L
J Neurol; 1987 Dec; 235(2):102-4. PubMed ID: 2828556
[TBL] [Abstract][Full Text] [Related]
5. Serologic studies of MS patients, controls, and patients with other neurologic diseases: antibodies to HTLV-I, II, III.
Madden DL; Mundon FK; Tzan NR; Fuccillo DA; Dalakas MC; Calabrese V; Elizan TS; Sever JL
Neurology; 1988 Jan; 38(1):81-4. PubMed ID: 2827054
[TBL] [Abstract][Full Text] [Related]
6. Increased reactivity to HTLV-I in inflammatory nervous system diseases.
Lolli F; Fredrikson S; Kam-Hansen S; Link H
Ann Neurol; 1987 Jul; 22(1):67-71. PubMed ID: 2888429
[TBL] [Abstract][Full Text] [Related]
7. Importance of western blot analysis in predicting infectivity of anti-HTLV-III/LAV positive blood.
Esteban JI; Shih JW; Tai CC; Bodner AJ; Kay JW; Alter HJ
Lancet; 1985 Nov; 2(8464):1083-6. PubMed ID: 2865566
[TBL] [Abstract][Full Text] [Related]
8. Determination of antibodies against LAV/HTLV III: comparative evaluation of four different commercial test kits.
Abb J
AIDS Res; 1986; 2(2):93-7. PubMed ID: 3013224
[TBL] [Abstract][Full Text] [Related]
9. Western blot technique in the serological evaluation of three LAV/HTLV III-infected Italian families.
Geroldi D; Aricò M; Plebani A; Maccario R; Notarangelo LD; Duse M; Rey F; Barrè Sinoussi F; Chermann JC; Burgio GR
Infection; 1986; 14(2):60-3. PubMed ID: 3011677
[TBL] [Abstract][Full Text] [Related]
10. Lymphadenopathy associated virus/human T-cell lymphotropic virus III antibodies in homosexual men with and without sperm antibodies.
Wolff H; Schill WB; Meurer M; von der Helm K; Guertler L
Fertil Steril; 1986 Jul; 46(1):111-3. PubMed ID: 3013695
[TBL] [Abstract][Full Text] [Related]
11. Analysis of human T-lymphotrophic virus sequences in multiple sclerosis tissue.
Hauser SL; Aubert C; Burks JS; Kerr C; Lyon-Caen O; de The G; Brahic M
Nature; 1986 Jul 10-16; 322(6075):176-7. PubMed ID: 3014351
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a new assay for antibodies to LAV/HTLV III.
Maskill W; Healey D; Wootten A; Silvester C; Johnson S; O'Dwyer C; Jacklin R; Pringle R; Gust I; Harden P
J Virol Methods; 1986 Jul; 13(4):273-8. PubMed ID: 3018016
[TBL] [Abstract][Full Text] [Related]
13. Testing for antibodies to AIDS-associated retrovirus (HTLV-III/LAV) by indirect fixed cell immunofluorescence: specificity, sensitivity, and applications.
Hedenskog M; Dewhurst S; Ludvigsen C; Sinangil F; Rodriguez L; Wu YT; Volsky DJ
J Med Virol; 1986 Aug; 19(4):325-34. PubMed ID: 3018138
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of HTLV-III/LAV in household contacts of patients with confirmed AIDS and controls in Kinshasa, Zaire.
Mann JM; Quinn TC; Francis H; Nzilambi N; Bosenge N; Bila K; McCormick JB; Ruti K; Asila PK; Curran JW
JAMA; 1986 Aug; 256(6):721-4. PubMed ID: 3014178
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to acquired immune deficiency syndrome (AIDS)-associated virus (HTLV-III/LAV) in Venezuelan populations.
Volsky DJ; Rodriguez L; Dewhurst S; Sinangil F; Sakai K; Merino F; Esparza B; De Salvo L
AIDS Res; 1986; 2(2):79-92. PubMed ID: 3013223
[TBL] [Abstract][Full Text] [Related]
16. Seroreactivity to human T cell leukemia/lymphoma virus type 1 and related retroviruses in multiple sclerosis patients from Denmark and the Faroes.
Rasmussen HB; Kvinesdal BB; Clausen J
Acta Neurol Scand; 1992 Jul; 86(1):91-4. PubMed ID: 1325731
[TBL] [Abstract][Full Text] [Related]
17. An immunoglobulin G capture assay (GACRIA) for anti-HTLV III/LAV and its use as a confirmatory test.
Parry JV
J Med Virol; 1986 Aug; 19(4):387-97. PubMed ID: 3018141
[TBL] [Abstract][Full Text] [Related]
18. LAV/HTLV-III antibodies in patients treated with intravenous gammaglobulins.
Kanoh T; Ohno T; Funakoshi N; Fujii H; Okada T
Tohoku J Exp Med; 1986 Nov; 150(3):361-2. PubMed ID: 2435020
[TBL] [Abstract][Full Text] [Related]
19. Detection of acquired immunodeficiency syndrome (AIDS) retrovirus antibody by lymphadenopathy-associated virus (LAV) enzyme immunoassay in low- and high-risk populations.
Ragni MV; Lewis JH; Bracken M; Toth R; Stokes J; Steffensen DO
Transfusion; 1986; 26(3):299-301. PubMed ID: 3010516
[TBL] [Abstract][Full Text] [Related]
20. Regional variation in prevalence of antibody against human T-lymphotropic virus types I and III in Kenya, East Africa.
Biggar RJ; Johnson BK; Oster C; Sarin PS; Ocheng D; Tukei P; Nsanze H; Alexander S; Bodner AJ; Siongok TA
Int J Cancer; 1985 Jun; 35(6):763-7. PubMed ID: 2989191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
